Revolution Medicines Inc (RVMD) — Working Capital to Net Assets Ratio
Revolution Medicines Inc (RVMD) has a Working Capital to Net Assets ratio of 111.9% as of March 2026. Working capital of $1.68 Billion (current assets of $1.97 Billion minus current liabilities of $289.60 Million) is measured against net assets of $1.50 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See financial flexibility index of Revolution Medicines Inc to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Revolution Medicines Inc Working Capital to Net Assets (2017–2025)
This chart shows how Revolution Medicines Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 111.9%, reflecting working capital of $1.68 Billion against net assets of $1.50 Billion USD. See Revolution Medicines Inc defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Revolution Medicines Inc (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Revolution Medicines Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Revolution Medicines Inc market cap and net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 109.4% | $1.78 Billion | $1.63 Billion | $2.08 Billion | $290.42 Million | ▲ +13.9 pp |
| 2024 | 95.5% | $2.16 Billion | $2.27 Billion | $2.33 Billion | $163.91 Million | ▲ +0.5 pp |
| 2023 | 95.0% | $1.74 Billion | $1.83 Billion | $1.88 Billion | $143.85 Million | ▲ +7.7 pp |
| 2022 | 87.3% | $598.20 Million | $685.19 Million | $660.18 Million | $61.98 Million | ▼ -0.6 pp |
| 2021 | 87.9% | $529.42 Million | $602.57 Million | $589.77 Million | $60.35 Million | ▲ +2.1 pp |
| 2020 | 85.7% | $406.95 Million | $474.68 Million | $454.12 Million | $47.18 Million | ▲ +26.1 pp |
| 2019 | 59.6% | $90.93 Million | $152.53 Million | $133.98 Million | $43.05 Million | ▲ +2.8 pp |
| 2018 | 56.8% | $54.88 Million | $96.66 Million | $85.43 Million | $30.55 Million | ▲ +16.1 pp |
| 2017 | 40.7% | $1.84 Million | $4.53 Million | $9.44 Million | $7.60 Million | — |